As of 2024-12-12, the Fair Value of Redwood Pharma AB (REDW.ST) is -25.62 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.18 SEK, the upside of Redwood Pharma AB is -2,261.64%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -15.76 | -14.53 | -20.84 | -13.04 | -14.18 | -15.67 |
| YoY growth | -12.81% | 7.80% | -43.43% | 37.43% | -8.78% | -3.96% |
| Market Cap (mil) | 3.15 |
| P/E | |
| Forward P/E |
| EPS | -5.12 |
| Avg earnings growth rate | -3.96% |
| TTM earnings | -13.60 |